Mylan Institutional, Inc.: Drug Recall
Recall #D-0291-2025 · 03/07/2025
Class II: Risk
Recall Details
- Recall Number
- D-0291-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Mylan Institutional, Inc.
- Status
- Ongoing
- Date Initiated
- 03/07/2025
- Location
- Rockford, IL, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,068 cartons
Reason for Recall
Super-Potent Drug: Out of specification potency results were obtained.
Product Description
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-443-20.
Distribution Pattern
Nationwide in the USA
Other Recalls by Mylan Institutional, Inc.
- Class II: Risk 03/07/2025
- Class II: Risk 11/19/2024
- Class II: Risk 11/19/2024
- Class II: Risk 11/19/2024
- Class II: Risk 11/19/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.